Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
56.18
+3.07 (5.78%)
Feb 27, 2026, 10:46 AM EST - Market open
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $2.43 billion as of February 27, 2026. Its market cap has increased by 251.22% in one year.
Market Cap
2.43B
Enterprise Value
1.74B
1-Year Change
251.22%
Ranking
Category
Stock Price
$56.18
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $2.43B, an increase of 1,389.79%. That is a compound annual growth rate of 199.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 2.30B | 29.92% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 2.46B |
| Arcus Biosciences | 2.46B |
| Immunome | 2.41B |
| Mineralys Therapeutics | 2.30B |
| Ascentage Pharma Group International | 2.24B |
| Mesoblast | 2.22B |
| Ultragenyx Pharmaceutical | 2.22B |
| Maze Therapeutics | 2.22B |